SCM
PFE icon

SCS Capital Management’s Pfizer PFE Stock Holding History

SCS Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$666K Sell
27,645
-1,946
-7% -$50.9K 0.01% 334
2026
Q1 		$831K Sell
29,591
-669
-2% -$17.8K 0.01% 300
2025
Q4 		$753K Buy
30,260
+228
+0.8% +$5.75K 0.01% 312
2025
Q3 		$765K Sell
30,032
-524
-2% -$12.9K 0.01% 317
2025
Q2 		$741K Sell
30,556
-160
-0.5% -$3.73K 0.01% 322
2025
Q1 		$778K Buy
+30,716
New +$804K 0.01% 288

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SCS Capital Management's PFE Position: Q2 2026 in Review

SCS Capital Management reduced its Pfizer (PFE) stake by 6.6% in Q2 2026, selling an estimated $50.9K and leaving 27,645 shares worth $666K. The position accounts for 0.01% of the portfolio, ranked #334.

SCS Capital Management first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $831K in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SCS Capital Management held 27,645 shares of Pfizer worth $666K as of Q2 2026.
  • SCS Capital Management sold 1,946 Pfizer shares in Q2 2026, an estimated $50.9K.
  • Pfizer made up 0.01% of SCS Capital Management's portfolio in Q2 2026, its #334 holding.
  • SCS Capital Management first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's Pfizer position peaked at $831K in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.